DECITABINE
- Product NDC
- 50742-430
- 11-digit product format
- 507420430
- Labeler code
- 50742
- Product ID
- 50742-430_c71b018e-22c6-4c0f-a8e8-6e320822e092
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- decitabine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA210984
- Marketing category
- ANDA
- Marketing start
- 2019-09-25
- Marketing end
- 0000-00-00
- Substance
- DECITABINE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-430 | DECITABINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [INGENUS PHARMACEUTICALS, LLC] | 11 | Legacy NDC | 20241115_b3a26585-e247-4b2e-a4ce-817b3aac2ff3.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-430-01 | 50742043001 | 1 VIAL in 1 CARTON (50742-430-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2019-09-25 | 0000-00-00 | No | No | Current |